Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (551-560 of 706) with videos related to

Pageof 71
Sort By:
Journal of the American College of Cardiology|March 26, 2016
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet TherapyMuthiah Vaduganathan, Deepak L Bhatt, Byron L Cryer, et al.
The American Journal of Medicine|May 5, 2016
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT TrialMuthiah Vaduganathan, Christopher P Cannon, Byron L Cryer, et al.
Journal of the American College of Cardiology|April 6, 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarctionC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.
American Heart Journal|December 18, 2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialDavid A Morrow, Yunmei Wang, Kevin Croce, et al.
Cancer|December 21, 2006
Chemotherapy response is an important predictor of local recurrence in Ewing sarcomaPatrick P Lin, Norman Jaffe, Cynthia E Herzog, et al.
Circulation. Arrhythmia and Electrophysiology|January 27, 2016
Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) TrialAn H Bui, Christopher P Cannon, Philippe Gabriel Steg, et al.
Journal of Cardiovascular Computed Tomography|January 9, 2022
Impact of coronary artery calcium testing on patient managementWanda Y Wu, David W Biery, Adam N Berman, et al.
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.
Clinical Cardiology|July 4, 2012
Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelinesPei-Hsiu Huang, Charles X Kim, Amir Lerman, et al.
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Pageof 71

Showing results (551-560 of 706) with videos related to

Sort By:
Pageof 71
Journal of the American College of Cardiology|March 26, 2016
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet TherapyMuthiah Vaduganathan, Deepak L Bhatt, Byron L Cryer, et al.
The American Journal of Medicine|May 5, 2016
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT TrialMuthiah Vaduganathan, Christopher P Cannon, Byron L Cryer, et al.
Journal of the American College of Cardiology|April 6, 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarctionC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.
American Heart Journal|December 18, 2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialDavid A Morrow, Yunmei Wang, Kevin Croce, et al.
Cancer|December 21, 2006
Chemotherapy response is an important predictor of local recurrence in Ewing sarcomaPatrick P Lin, Norman Jaffe, Cynthia E Herzog, et al.
Circulation. Arrhythmia and Electrophysiology|January 27, 2016
Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) TrialAn H Bui, Christopher P Cannon, Philippe Gabriel Steg, et al.
Journal of Cardiovascular Computed Tomography|January 9, 2022
Impact of coronary artery calcium testing on patient managementWanda Y Wu, David W Biery, Adam N Berman, et al.
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.
Clinical Cardiology|July 4, 2012
Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelinesPei-Hsiu Huang, Charles X Kim, Amir Lerman, et al.
The New England Journal of Medicine|September 3, 2013
Alogliptin after acute coronary syndrome in patients with type 2 diabetesWilliam B White, Christopher P Cannon, Simon R Heller, et al.
Pageof 71